Antitumor agent-176
Product Specifications
Target
FGFR
Related Pathways
Angiogenesis, Tyrosine Kinase/Adaptors
Bioactivity
Antitumor agent-176 (Compound 22) is an antitumor agent that binds effectively to FGF2, inhibits the activation of fibroblast growth factor receptor (FGFR) in multiple myeloma (MM) cells, and demonstrates significant antitumor activity against MM both in vivo and in vitro.
Molecular Formula
C21H16F6O3
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1197518-01 0.02 mg (E-Coli)
Recombinant Arthroderma benhamiae Probable extracellular metalloproteinase 1 (MEP1)
Sign In for Pricing
View Details MBS1197518-02 0.02 mg (Yeast)
Recombinant Arthroderma benhamiae Probable extracellular metalloproteinase 1 (MEP1)
Sign In for Pricing
View Details MBS1197518-03 0.1 mg (E-Coli)
Recombinant Arthroderma benhamiae Probable extracellular metalloproteinase 1 (MEP1)
Sign In for Pricing
View Details MBS1197518-04 0.1 mg (Yeast)
Recombinant Arthroderma benhamiae Probable extracellular metalloproteinase 1 (MEP1)
Sign In for Pricing
View Details MBS1197518-05 0.02 mg (Baculovirus)
Recombinant Arthroderma benhamiae Probable extracellular metalloproteinase 1 (MEP1)
Sign In for Pricing
View Details MBS1197518-06 0.02 mg (Mammalian-Cell)
Recombinant Arthroderma benhamiae Probable extracellular metalloproteinase 1 (MEP1)
Sign In for Pricing
View Details